Health Care [ 3/12 ] | Health Care Equipment & Supplies [ 22/74 ]
NYSE | Common Stock
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
The company operates in two segments, Sleep and Respiratory Care, and Software as a Service.
It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.
It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions.
The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.
ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 24, 24 | 2.20 Increased by +34.15% | 2.04 Increased by +7.84% |
| Aug 1, 24 | 2.08 Increased by +30.00% | 2.07 Increased by +0.48% |
| Apr 25, 24 | 2.13 Increased by +26.79% | 1.91 Increased by +11.52% |
| Jan 24, 24 | 1.88 Increased by +13.25% | 1.80 Increased by +4.44% |
| Oct 26, 23 | 1.64 Increased by +8.61% | 1.62 Increased by +1.23% |
| Aug 3, 23 | 1.60 Increased by +7.38% | 1.69 Decreased by -5.33% |
| Apr 27, 23 | 1.68 Increased by +27.27% | 1.59 Increased by +5.66% |
| Jan 26, 23 | 1.66 Increased by +12.93% | 1.62 Increased by +2.47% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 1.22 B Increased by +27.15% | 311.36 M Increased by +41.90% | Increased by +25.43% Increased by +11.60% |
| Jun 30, 24 | 1.22 B Increased by +9.01% | 292.24 M Increased by +27.25% | Increased by +23.89% Increased by +16.72% |
| Mar 31, 24 | 1.20 B Increased by +7.17% | 300.49 M Increased by +29.24% | Increased by +25.10% Increased by +20.60% |
| Dec 31, 23 | 1.16 B Increased by +12.48% | 208.80 M Decreased by -7.16% | Increased by +17.96% Decreased by -17.47% |
| Sep 30, 23 | 963.04 M Increased by +1.34% | 219.42 M Increased by +4.25% | Increased by +22.78% Increased by +2.87% |
| Jun 30, 23 | 1.12 B Increased by +22.66% | 229.66 M Increased by +17.74% | Increased by +20.47% Decreased by -4.01% |
| Mar 31, 23 | 1.12 B Increased by +29.20% | 232.50 M Increased by +29.88% | Increased by +20.82% Increased by +0.53% |
| Dec 31, 22 | 1.03 B Increased by +15.52% | 224.91 M Increased by +11.48% | Increased by +21.76% Decreased by -3.50% |